Zoladex and Spiriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoladex (goserelin acetate) and Spiriva (tiotropium bromide monohydrate). Common drug interactions include fatigue among females and prostate cancer recurrent among males.

The phase IV clinical study analyzes what interactions people have when they take Zoladex and Spiriva. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Zoladex?

Zoladex has active ingredients of goserelin acetate. It is often used in prostate cancer. eHealthMe is studying from 13,870 Zoladex users. Check the latest studies of Zoladex.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

78 people who take Zoladex and Spiriva together, and have interactions are studied.

Zoladex and Spiriva drug interactions.

What are the common drug interactions of Zoladex and Spiriva, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Gait disturbance
  3. General physical health deterioration (weak health status)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Neoplasm progression (growth of tumour)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Vitritis (inflammation of the vitreous humour of the eye)
  8. Gynaecomastia (enlargement of the gland tissue of the male breast)
  9. Leukoencephalopathy (disease of the white matter in the brain)
  10. Spinal compression fracture (fracture due to spinal compression on bone)

male:

  1. Prostate cancer recurrent
  2. Anaemia (lack of blood)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Transferrin decreased
  5. Osteitis (a general term for inflammation of bone)
  6. Nausea (feeling of having an urge to vomit)
  7. Platelet count decreased
  8. Death
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Blood pressure decreased

What are the common drug interactions of Zoladex and Spiriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back pain
  2. Bone pain
  3. Cardiac failure
  4. Fatigue (feeling of tiredness)
  5. Gait disturbance
  6. General physical health deterioration (weak health status)
  7. Malignant neoplasm progression (cancer tumour came back)
  8. Neoplasm progression (growth of tumour)
  9. Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

n/a

50-59:

  1. Extraskeletal ossification (formation of bone tissue outside of bone tissue)
  2. Gynaecomastia (enlargement of the gland tissue of the male breast)
  3. Hilar lymphadenopathy (disease of the lymph nodes due to infection)
  4. Injury
  5. Lung neoplasm (tumour of lung)
  6. Metastases to bone (cancer spreads to bone)
  7. Metastatic neoplasm (spreadable cancer tumour)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Pain
  10. Prostate cancer metastatic

60+:

  1. Prostate cancer recurrent
  2. General physical health deterioration (weak health status)
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Transferrin decreased
  5. Osteitis (a general term for inflammation of bone)
  6. Nausea (feeling of having an urge to vomit)
  7. Death
  8. Platelet count decreased
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Blood pressure decreased

What are the existing conditions these people have? *

  1. High Blood Pressure: 12 people, 15.38%
  2. Prostate Cancer Metastatic: 10 people, 12.82%
  3. Acute Myocardial Infarction (acute heart attack): 7 people, 8.97%
  4. Renal Cell Carcinoma (a kidney cancer): 6 people, 7.69%
  5. Diabetes: 6 people, 7.69%
  6. Weight Loss: 5 people, 6.41%
  7. Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 6.41%
  8. High Blood Cholesterol: 5 people, 6.41%
  9. Dyspnea (difficult or laboured breathing): 5 people, 6.41%

* Approximation only. Some reports may have incomplete information.

Do you take Zoladex and Spiriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zoladex and Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zoladex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zoladex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on goserelin acetate and tiotropium bromide monohydrate (the active ingredients of Zoladex and Spiriva, respectively), and Zoladex and Spiriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: